30 ML mepivacaine hydrochloride 10 MG/ML Injection — RxCUI 1866503
RxNorm drug concept · Semantic clinical drug
RxCUI 1866503
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
7 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1866503
Official name30 ML mepivacaine hydrochloride 10 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmepivacaine HCl 1 % per 30 ML Injection; mepivacaine HCl 1 % in 30 ML Injection
FDA products mapped6
Package NDCs mapped7
Reported Medicaid activity (SDUD)1,421 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How 30 ML mepivacaine hydrochloride 10 MG/ML Injecti... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
30 ML mepivacaine hydrochloride 10 MG/ML Injection
RxCUI 1866503 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Mepivacaine
6759IN -
Mepivacaine hydrochloride
203185PIN
-
Mepivacaine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Polocaine
684878BN
-
Polocaine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Mepivacaine Injection
1866502SCDF -
Mepivacaine hydrochloride Injection
2649156SCDFP -
Mepivacaine Injectable Product
1160404SCDG -
Mepivacaine hydrochloride Injectable Product
2663332SCDGP -
Mepivacaine Injection [Polocaine]
1866514SBDF -
Mepivacaine hydrochloride Injection [Polocaine]
2658257SBDFP -
Polocaine Injectable Product
1182424SBDG -
Injection
1649574DF - +1 more in this family
-
Mepivacaine Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Mepivacaine hydrochloride 10 MG/ML
1012721SCDC -
30 ML mepivacaine hydrochloride 10 MG/ML Injection [Polocaine]
1866515SBD -
Mepivacaine hydrochloride 10 MG/ML [Polocaine]
1012725SBDC
-
Mepivacaine hydrochloride 10 MG/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Mepivacaine hydrochloride 10 MG/ML
SCDC · 1012721 -
Mepivacaine Injection
SCDF · 1866502 -
Mepivacaine hydrochloride Injection
SCDFP · 2649156 -
Mepivacaine Injectable Product
SCDG · 1160404 -
Mepivacaine hydrochloride Injectable Product
SCDGP · 2663332
Brand-Name Concepts
-
30 ML mepivacaine hydrochloride 10 MG/ML Injection [Polocaine]
SBD · 1866515 -
Mepivacaine hydrochloride 10 MG/ML [Polocaine]
SBDC · 1012725 -
Mepivacaine Injection [Polocaine]
SBDF · 1866514 -
Mepivacaine hydrochloride Injection [Polocaine]
SBDFP · 2658257 -
Polocaine Injectable Product
SBDG · 1182424 -
Polocaine
BN · 684878
📦 FDA Products & Package NDCs
6 products · 7 package NDCs
7 package NDCs map to RxCUI 1866503 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 51662-1403-01 | 30 mL in 1 VIAL, SINGLE-DOSE (51662-1403-1) | POLOCAINE(R) -MPF (MEPIVACAINE HCI) | HF Acquisition Co LLC, DBA HealthFirst | 2019-12-10 |
| 51662-1403-03 | 25 POUCH in 1 CASE (51662-1403-3) / 1 VIAL, SINGLE-DOSE in... | POLOCAINE(R) -MPF (MEPIVACAINE HCI) | HF Acquisition Co LLC, DBA HealthFirst | 2023-01-08 |
| 63323-0260-37 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-260-37) / 30 mL in 1... | Polocaine-MPF | Fresenius Kabi USA, LLC | 2009-07-20 |
| 63323-0283-57 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-283-57) / 50 mL in 1 V... | Polocaine | Fresenius Kabi USA, LLC | 2009-07-20 |
| 63323-0293-37 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-293-37) / 30 mL in 1... | Polocaine-MPF | Fresenius Kabi USA, LLC | 2009-07-21 |
| 63323-0294-27 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-294-27) / 20 mL in 1... | Polocaine-MPF | Fresenius Kabi USA, LLC | 2009-07-21 |
| 63323-0296-57 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-296-57) / 50 mL in 1 V... | Polocaine | Fresenius Kabi USA, LLC | 2009-07-20 |
Observed labelers:
Fresenius Kabi USA, LLC (5) ·
HF Acquisition Co LLC, DBA HealthFirst (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0670 | Inj mepivacaine hcl/10 ml | 7 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.